Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Infiltrating Lymphocyte”

252 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 252 results

Not applicableStudy completedNCT01715077
What this trial is testing

Study of Ipilimumab in the Immune System

Who this might be right for
Previously Untreated and Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma
University Health Network, Toronto 4
Not applicableActive Not RecruitingNCT05524012
What this trial is testing

Longitudinal Multimodal Response Assessment During Neoadjuvant Treatment of Rectal Cancer

Who this might be right for
Locally Advanced Rectal CarcinomaNeoadjuvant TreatmentRadiotherapy+1 more
Jena University Hospital 40
Not applicableLooking for participantsNCT04902937
What this trial is testing

Association of Adjuvant Radiotherapy of Non-metastatic Breast Carcinoma With Immunomodulation and Circulating Tumor Cell Phenotype in Relation to Patient Age.

Who this might be right for
Tumor Cell, Circulating
University of Jena 200
Early research (Phase 1)Ended earlyNCT05107739
What this trial is testing

DeTIL-0255 in Adults With Advanced Malignancies

Who this might be right for
Platinum-resistant Ovarian CancerEndometrial CancerCervical Cancer
Nurix Therapeutics, Inc. 5
Early research (Phase 1)Active Not RecruitingNCT05768347
What this trial is testing

Intravesical Adoptive Cell Therapy w/ TIL for BCG Exposed High Grade NMIBC

Who this might be right for
Urothelial CarcinomaNon-Invasive Bladder Urothelial Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 9
Testing effectiveness (Phase 2)Ended earlyNCT02375984
What this trial is testing

A Study Using Tumor-Reactive Autologous Tumor Infiltrating Lymphocytes (TIL) in Metastatic Melanomas

Who this might be right for
Metastatic Melanoma
Saint John's Cancer Institute 1
Testing effectiveness (Phase 2)Ended earlyNCT03645928
What this trial is testing

Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors

Who this might be right for
Metastatic MelanomaSquamous Cell Carcinoma of the Head and NeckNon-small Cell Lung Cancer
Iovance Biotherapeutics, Inc. 225
Testing effectiveness (Phase 2)UnknownNCT00604136
What this trial is testing

Treatment of Metastatic Melanoma With Tumor Infiltrating Lymphocytes and IL-2 Following Lympho-depleting Chemotherapy

Who this might be right for
Metastatic Melanoma
Hadassah Medical Organization 20
Early research (Phase 1)Looking for participantsNCT06783270
What this trial is testing

T-cell Therapy with CRISPR PD1-edited Tumor Infiltrating Lymphocytes for Patients with Metastatic Melanoma

Who this might be right for
Melanoma Metastatic
Inge Marie Svane 10
Testing effectiveness (Phase 2)Study completedNCT02493361
What this trial is testing

Trial of pIL-12/MK-3475 in Metastatic Melanoma

Who this might be right for
Melanoma
University of California, San Francisco 24
Not applicableNot Yet RecruitingNCT07819474
What this trial is testing

Optimizing Tumor-Infiltrating Lymphocyte (TIL) Harvest Site and Patient Selection With CD8-PET Imaging in Patients With

Who this might be right for
Tumor Infiltrating LymphocyteCD8-PETAdvanced Melanoma
M.D. Anderson Cancer Center 6
Very early researchUnknownNCT05333588
What this trial is testing

The Safety Study of Autologous TILs Therapy for Patients With Glioblastoma Multiforme.

Who this might be right for
Glioblastoma Multiforme, Adult
Hebei Senlang Biotechnology Inc., Ltd. 20
Early research (Phase 1)Looking for participantsNCT07443020
What this trial is testing

Fast TILs to Treat Metastatic Pleural Effusions From Epithelial or Mesothelial Primary Tumors

Who this might be right for
Malignant Pleural EffusionMalignant MesotheliomaPleural Effusion, Malignant+1 more
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) 10
Not applicableNot Yet RecruitingNCT07028008
What this trial is testing

Evaluate the Safety and Efficacy of Autologous Tumor-infiltrating Lymphocyte in Patients With Refractory Melanoma Who Failed to Immune Checkpoint Inhibitors

Who this might be right for
Melanoma
Samsung Medical Center 9
Not applicableAvailableNCT05398640
What this trial is testing

Expanded Access Program of AMTAGVI That is Out of Specification for Commercial Release

Who this might be right for
Unresectable MelanomaMetastatic Melanoma
Iovance Biotherapeutics, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT03610490
What this trial is testing

Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Colorectal Cancer, or Pancreatic Ductal Adenocarcinoma

Who this might be right for
Malignant Solid NeoplasmMetastatic Colorectal AdenocarcinomaMetastatic Ovarian Carcinoma+9 more
M.D. Anderson Cancer Center 16
Early research (Phase 1)Active Not RecruitingNCT05176470
What this trial is testing

Neoadj Admin Autologous Tumor Infiltrating Lymphocytes & Pembrolizumab for Treatment of Adv Melanoma Patients

Who this might be right for
Locally Advanced MelanomaPathologic Stage IIIB Cutaneous Melanoma AJCC v8Pathologic Stage IIIC Cutaneous Melanoma AJCC v8+2 more
Richard Wu 2
Very early researchLooking for participantsNCT07349160
What this trial is testing

Safety and Efficacy of Metabolically Armed Tumor-Infiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 36
Not applicableStudy completedNCT03348891
What this trial is testing

TNF in Melanoma Patients Treated With Immunotherapy

Who this might be right for
Melanoma
Institut Claudius Regaud 60
Testing effectiveness (Phase 2)Looking for participantsNCT01174121
What this trial is testing

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer

Who this might be right for
Metastatic Colorectal CancerMetastatic Pancreatic CancerMetastatic Ovarian Cancer+2 more
National Cancer Institute (NCI) 332
Next Page